REQUEST A DEMO
Total
USD $0.00
Search more companies

Quantumpharm Cia.Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Cyclic Crude, Intermediate, and Gum and Wood Chemical Manufacturing
Full name: Quantumpharm Cia.Ltda Profile Updated: February 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Quantumpharm Cia.Ltda is based in Ecuador. The head office is in Quito. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on July 16, 1997. 63 (2024) employees currently work for Quantumpharm Cia.Ltda. The company’s latest financial report indicates a net sales revenue increase of 63.1% in 2024. Its’ total assets recorded a growth of 94.18%.

Headquarters
Juan Campuzano N85-75
Quito; Pichincha;

Contact Details: Purchase the Quantumpharm Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Quantumpharm Cia.Ltda report to view the information.
Registered Capital:
Purchase the Quantumpharm Cia.Ltda report to view the information.
Financial Auditors:
Purchase the Quantumpharm Cia.Ltda report to view the information.
Incorporation Date:
July 16, 1997
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
23%
Purchase this report to view the information.
17%
Company Performance
Financial values in the chart are available after Quantumpharm Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
63.1%
Total operating revenue
63.1%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
94.18%
Total equity
8.73%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-0.44%
Quick Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?